Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Skin Whitening Article on CNN News online tonight

<< Previous

Bullboard Posts

Next >>

Comment by lscfaon Jan 27, 2022 11:30am

124 Views

Post# 34366750

RE:RE:Skin Whitening Article on CNN News online tonight

Exactly. And R+F made it even less obvious that 1067 was the active ingredient by including several other proprietary ingredients in its cream.

Turtle4 wrote: Sirona does not have a "Skin whitener".

They have a "Dark Spot Remover".
They made studies, that show, that TFC-1067 only works on dark spots and does not affect the overall skin color.

<< Previous

Bullboard Posts

Next >>

Understanding tax loss season and the “Santa Claus rally”